Mutation of a putative amphipathic α-helix in the third intracellular domain of the platelet-activating factor receptor disrupts receptor G protein coupling and signaling

被引:10
|
作者
Carlson, SA
Chatterjee, TK
Murphy, KP
Fisher, RA [1 ]
机构
[1] Univ Iowa, Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA
关键词
D O I
10.1124/mol.53.3.451
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Platelet-activating factor (PAF) is a potent phospholipid mediator that interacts with G protein-coupled PAF receptors to elicit diverse physiological and pathophysiological actions. We recently demonstrated that the third intracellular domain of the rat PAF receptor (rPAFR) is a critical determinant in its coupling to phosphoinositide phospholipase C-activating G proteins. Here, we report identification of a putative amphipathic helix in the third intracellular domain of the rPAFR and the effects of mutational disruption of its amphipathic character on G protein coupling of and signaling by the rPAFR. Modeling of the third intracellular domain and adjacent transmembrane regions of the rPAFR identified a single amphipathic helix located in the amino-terminal region of the third intracellular domain of the receptor. Baby hamster kidney cells were transiently transfected with cDNAs encoding the rPAFR or rPAFR mutants in which nonconserved substitutions were made separately in the hydrophobic or polar face of this amphipathic helix. The number and affinity of binding sites for specific PAF receptor antagonist WEB2086 were identical in membranes prepared from rPAFR and amphipathic helix mutant PAFR transfectants. However, only membranes derived from rPAFR transfectants possessed high affinity PAF binding sites that were sensitive to the G protein-uncoupling effects of guanosine-5'-O-(3-thio)triphosphate. These results show that substitutions into either face of the amphipathic helical domain abolished the ability of the rPAFR to undergo coupling to G proteins to form a high affinity agonist/receptor/G protein ternary complex. To examine the effects of these mutations on rPAFR signaling, PAF-stimulated inositol phosphate accumulation was determined in cells transfected with cDNAs encoding the wild-type or amphipathic helix mutant PAFRs. Although PAF stimulated 10-fold in creases in inositol phosphate accumulation in rPAFR transfectants, it had no effects on inositol phosphate accumulation in amphipathic helix mutant PAFR transfectants. These results suggest that an amphipathic helix located in the amino-terminal region of the third intracellular domain of the rPAFR is required for its coupling to and activation of G proteins. This study provides the first insight into the structure of the receptor interface for G protein coupling of a PAFR and suggests a conserved role of amphipathic helices in G protein coupling of receptors ranging from those for biogenic amines to the phospholipid mediator PAF.
引用
收藏
页码:451 / 458
页数:8
相关论文
共 50 条
  • [31] Platelet-Activating Factor: a Role in Preterm Delivery and an Essential Interaction with Toll-Like Receptor Signaling in Mice
    Agrawal, Varkha
    Jaiswal, Mukesh Kumar
    Ilievski, Vladimir
    Beaman, Kenneth D.
    Jilling, Tamas
    Hirsch, Emmet
    BIOLOGY OF REPRODUCTION, 2014, 91 (05)
  • [32] Polyunsaturated fatty acids (PUFA) modulate platelet-activating factor (PAF) receptor-mediated signaling pathways
    Lu, J
    Caplan, MS
    Jilling, T
    FASEB JOURNAL, 2006, 20 (05): : A1232 - A1232
  • [33] Albuterol Isomers Modulate Platelet-Activating Factor Synthesis and Receptor Signaling in Human Bronchial Smooth Muscle Cells
    Bae, Rena
    Arteaga, Alba
    Raj, J. Usha
    Ibe, Basil O.
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2012, 158 (01) : 18 - 26
  • [34] Up-regulation of the intracellular Ca2+ signaling and mRNA expression of platelet-activating factor receptor by estradiol in human uterine endometrial cells
    Sato, S
    Kume, K
    Takan, T
    Mutoh, H
    Taketani, Y
    Shimizu, T
    PLATELET-ACTIVATING FACTOR AND RELATED LIPID MEDIATORS 2: ROLES IN HEALTH AND DISEASE, 1996, 416 : 95 - 100
  • [35] A mutation in the second transmembrane region of the CB1 receptor selectively disrupts G protein signaling and prevents receptor internalization
    Roche, JP
    Bounds, S
    Brown, S
    Mackie, K
    MOLECULAR PHARMACOLOGY, 1999, 56 (03) : 611 - 618
  • [36] A1 adenosine receptor signaling reduces Streptococcus pneumoniae adherence to pulmonary epithelial cells by targeting expression of platelet-activating factor receptor
    Bhalla, Manmeet
    Yeoh, Jun Hui
    Lamneck, Claire
    Herring, Sydney E.
    Tchalla, Essi Y. I.
    Heinzinger, Lauren R.
    Leong, John M.
    Ghanem, Elsa N. Bou
    CELLULAR MICROBIOLOGY, 2020, 22 (02)
  • [37] Lysine 270 in the third intracellular domain of the oxytocin receptor is an important determinant for Gαq coupling specificity
    Yang, M
    Wang, W
    Zhong, M
    Philippi, A
    Lichtarge, O
    Sanborn, BM
    MOLECULAR ENDOCRINOLOGY, 2002, 16 (04) : 814 - 823
  • [38] Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer
    Souza, Juliana L.
    Martins-Cardoso, Karina
    Guimaraes, Isabella S.
    de Melo, Andreia C.
    Lopes, Angela H.
    Monteiro, Robson Q.
    Almeida, Vitor H.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [39] Involvement of leukotriene B4 receptor 1 signaling in platelet-activating factor-mediated neutrophil degranulation and chemotaxis
    Gaudreault, E
    Stankova, J
    Rola-Pleswzynski, M
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2005, 75 (1-4) : 25 - 34
  • [40] Localization of the platelet-activating factor (PAF) receptor on stallion spermatozoa by immunofluorescent microscopy and PAF mobilization of intracellular calcium as determined by flow cytometry
    Eng, LA
    Odeh, AI
    Dascanio, JJ
    Caceci, T
    Bowen, J
    Roudebush, WE
    BIOLOGY OF REPRODUCTION, 2003, 68 : 171 - 171